They pared their gains and were last up 2%. The Maryland-based biotech announced the clinical hold last month after a ...

The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

Misconceptions about the influenza and COVID-19 vaccines may make some people hesitant to roll up their sleeves. What better way to clear up the confusion than hearing straight from a Mayo Clinic ...

Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...

So far this year, 18 countries have registered a total of 278 HPAI outbreaks in poultry. This is according to the Animal ...

(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...

On Monday, the FDA removed the clinical hold on Novavax Inc.’s (NASDAQ:NVAX) Investigational New Drug (IND) application for ...

The Middle East Veterinary Vaccine Market is poised for steady growth, with a projected market size of USD 627.1 million in 2023. The market is expected to expand at a CAGR of 4% through 2033, ...

and stand-alone influenza vaccine candidates. The FDA has cleared the Company to begin enrolling the planned Phase 3 trial ...

and stand-alone influenza vaccine candidates. The vaccine candidates were placed on clinical hold last month after report of a serious adverse event in a single CIC Phase 2 trial participant who ...